Pages that link to "Q38353232"
Jump to navigation
Jump to search
The following pages link to Antigen binding and cytotoxic properties of a recombinant immunotoxin incorporating the lytic peptide, melittin (Q38353232):
Displaying 10 items.
- Three valuable peptides from bee and wasp venoms for therapeutic and biotechnological use: melittin, apamin and mastoparan (Q38401839) (← links)
- MDX-1097 induces antibody-dependent cellular cytotoxicity against kappa multiple myeloma cells and its activity is augmented by lenalidomide (Q38912820) (← links)
- Application of bee venom and its main constituent melittin for cancer treatment (Q38966140) (← links)
- Construction and expression of sTRAIL-melittin combining enhanced anticancer activity with antibacterial activity in Escherichia coli (Q39245378) (← links)
- Interaction of melittin with a human lymphoblastoid cell line, HMy2 (Q41069634) (← links)
- A pH-dependent Antibacterial Peptide Release Nano-system Blocks Tumor Growth in vivo without Toxicity (Q41328493) (← links)
- Adjuvant action of melittin following intranasal immunisation with tetanus and diphtheria toxoids (Q41462282) (← links)
- Expression in Pichia pastoris and purification of a membrane-acting immunotoxin based on a synthetic gene coding for the Bacillus thuringiensis Cyt2Aa1 toxin (Q42802381) (← links)
- IgM expressed by leukemic CD5(+) B cells binds mouse immunoglobulin light chain. (Q43704506) (← links)
- A preliminary study of the anti-κ myeloma antigen monoclonal antibody KappaMab (MDX-1097) in pretreated patients with κ-restricted multiple myeloma (Q92321868) (← links)